P
Peter Kreiner
Researcher at Brandeis University
Publications - 22
Citations - 2068
Peter Kreiner is an academic researcher from Brandeis University. The author has contributed to research in topics: Medical prescription & Opioid overdose. The author has an hindex of 17, co-authored 20 publications receiving 1742 citations.
Papers
More filters
Journal ArticleDOI
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Andrew Kolodny,David T. Courtwright,Catherine S. Hwang,Peter Kreiner,John L. Eadie,Thomas W. Clark,G. Caleb Alexander +6 more
TL;DR: The scope of this public health crisis, its historical context, contributing factors, and lines of evidence indicating the role of addiction in exacerbating morbidity and mortality, are described, and a framework for interventions to address the epidemic of opioid addiction is provided.
Journal ArticleDOI
Controlled substance prescribing patterns - Prescription Behavior Surveillance System, eight states, 2013
TL;DR: The trend in opioid prescribing rates with age is consistent with an increase in the prevalence of chronic pain with age, but the increasing prescribing rates of benzodiazepines withAge is not consistent with the fact that anxiety is most common among persons aged 30-44 years.
Journal ArticleDOI
Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006†
Nathaniel P. Katz,Lee Panas,Meelee Kim,Adele D. Audet,Arnold Bilansky,John L. Eadie,Peter Kreiner,Florence Paillard,Cindy Parks Thomas,Grant M. Carrow +9 more
TL;DR: 11 years of Massachusetts PMP data are analyzed to evaluate trends in opioid prescribing, dispensing, and usage.
Journal ArticleDOI
Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
TL;DR: Findings indicate that PDMP mandates have the potential to reduce risky opioid prescribing practices and variation in the laws may explain why the effectiveness varied between states.
Journal ArticleDOI
Prescribing Patterns of Buprenorphine Waivered Physicians
Cindy Parks Thomas,Erin Doyle,Peter Kreiner,Christopher M. Jones,Joel Dubenitz,Alexis Horan,Bradley D. Stein +6 more
TL;DR: For the few high prescribers, increasing the maximum patient limit beyond 100 has the potential to improve access but alone may not have widespread impact unless integrated into complementary approaches toward increasing prescriber capacity.